Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Carbacyclin, a PGI2 analog, is a prostacyclin (PGI2) receptor agonist and vasodilator with potent inhibitory platelet aggregation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 μg | 4-5 weeks | $ 233.00 | |
500 μg | 4-5 weeks | $ 383.00 |
Description | Carbacyclin, a PGI2 analog, is a prostacyclin (PGI2) receptor agonist and vasodilator with potent inhibitory platelet aggregation. |
In vitro | Carbacyclin acts as an inhibitor of platelet aggregation induced by ADP or collagen in vitro[2]. It also enhances CPT-1 mRNA expression through PPARδ, independent of the IP receptor signaling pathway. Furthermore, Carbacyclin, within the concentration range of 0.02 μM to 20 μM, activates the IP receptor signaling pathway through PKA, an effect that is blocked by H-89, a PKA inhibitor. Additionally, Carbacyclin, at concentrations ranging from 0.02 to 80 μM, increases PPRE promoter activity via PPARδ in cardiomyocytes, again independent of the IP receptor pathway[3]. |
In vivo | Carbacyclin is 0.03 times as active as prostacyclin on inhibiting platelet aggregation in human, rabbit, or dog plasma [2]. In the murine heart, Carbacyclin (100 μg, i.p.) induces CPT-1 mRNA expression [3]. |
Synonyms | Carbaprostacyclin, Carba-PGI2 |
Molecular Weight | 350.49 |
Formula | C21H34O4 |
CAS No. | 69552-46-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Carbacyclin 69552-46-1 Others Carbaprostacyclin Carba-PGI2 inhibitor inhibit